Zhongping Capital
Shanghai, Shanghaizhongpingcapital.com
Overview
Zhongping Capital is a leading alternative asset manager in China . The firm invests across finance services, TMT, healthcare, environmental services, new energy, and Industry 4.0 . Zhongping aims to create long-term value for its investors by adopting a patient “buy-and-hold” investment approach and helping its portfolio companies achieve their full potential with implementation of growth and best-practice operational strategies . Zhongping Capital incorporates ESG principles into its corporate strategy and the entire investment decision-making process, continuously contributing to the high-quality development of China's economy .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cascade Pharmaceuticals, Inc. | Feb 2026 | VC Round | Lead |
| Cascade Pharmaceuticals, Inc. | Feb 2026 | Early Funding | Lead |
| Xuzhou B&C Chemical Co.,Ltd. | Apr 2023 | VC Round | Lead |
| Bluepha | Feb 2023 | Debt | Lead |
| NeuroXess | Dec 2022 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.